Crossref
Long-Term Recurrence Risk in HR+/HER2− Early Breast Cancer: Evidence from a Canadian Cohort
Asian Journal of Current Research in Clinical Cancer · 2026 · 6 (1) · 239-259
DOI: 10.51847/txtdvdbaup ↗Kurz gefasst
Fachartikel in der Zeitschrift Asian Journal of Current Research in Clinical Cancer, 2026. Verfasst von Nguyen Thanh Huy und 2 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Huy, N. T., Minh, P. Q., & Bich, L. T. (2026). Long-Term Recurrence Risk in HR+/HER2− Early Breast Cancer: Evidence from a Canadian Cohort. Asian Journal of Current Research in Clinical Cancer, 6(1), 239-259. https://doi.org/10.51847/txtdvdbaup
Vancouver
Huy NT, Minh PQ, Bich LT. Long-Term Recurrence Risk in HR+/HER2− Early Breast Cancer: Evidence from a Canadian Cohort. Asian Journal of Current Research in Clinical Cancer. 2026;6(1):239-259. doi:10.51847/txtdvdbaup
BibTeX
@article{Huy2026,
author = {Huy, Nguyen Thanh and Minh, Pham Quang and Bich, Le Thi},
title = {Long-Term Recurrence Risk in HR+/HER2− Early Breast Cancer: Evidence from a Canadian Cohort},
journal = {Asian Journal of Current Research in Clinical Cancer},
year = {2026},
volume = {6},
number = {1},
pages = {239--259},
doi = {10.51847/txtdvdbaup}
}
EUVIMED